Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
1 other identifier
observational
5,861
1 country
26
Brief Summary
Hirsutism is defined as the excessive presence of terminal hairs in the androgen-sensitive areas of the female body, and it is one of the frequent reasons for presenting to dermatology outpatient clinics. Hirsutism influences 5% to 10% of women around the world and leads to psychological problems depending on ethnic and socio-cultural factors. It also causes material burden including medicines, cosmetic products and epilation procedures. The differences in the real prevalence of hirsutism in the Turkish population and the hirsutism prevalence and severity between the geographical regions of Turkey are not known. In this study, we aimed to determine the prevalence of hirsutism in women at the reproductive age within Turkey. The geographical regions of Turkey comprise seven regions and and all regions were included in this study. By considering the regions where ethnic differences were high including the east-west-south and north of our country, we aimed to find an answer to the question of whether there were differences in terms of the prevalence and severity of hirsutism among these regions. A comprehensive study aiming to determine the prevalence of hirsutism in Turkey has not been conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Shorter than P25 for all trials
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2020
CompletedFirst Submitted
Initial submission to the registry
February 26, 2020
CompletedFirst Posted
Study publicly available on registry
March 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedMarch 3, 2020
March 1, 2020
8 months
February 26, 2020
March 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified Ferriman-Gallwey Scoring System for Severity of Hirsutism
In this system, hair growth in nine regions (upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, upper arms and thighs) is graded between 0 and 4. And nine regions are scored between 0 (no terminal hairs) and 4 (excessive presence of terminal hairs). The score above 8 is considered hirsutism.
1 day (At the time of the examination)
Secondary Outcomes (5)
Number of Participants With Concomitant disease status and the risk factors
1 day (At the time of the examination)
Body mass indices of the participants
1 day (At the time of the examination)
The presence and severity of acne in the participants
1 day (At the time of the examination)
The presence and severity of androgenic alopecia in the participants
1 day (At the time of the examination)
Menstrual cycle pattern of the participants
1 day (At the time of the examination)
Study Arms (2)
Women with hirsutism
Women between the ages of 18-45 with hirsutism
Women without hirsutism
Women between the ages of 18-45 without hirsutism
Eligibility Criteria
During the study period, female patients aged between 18 and 45, who present to dermatology outpatient clinics, will be examined consecutive until the number of patients designated for each study center is reached.
You may qualify if:
- Female patients aged between 18 and 45, who presented to the dermatology outpatient clinics for any reason
- Not being in pregnancy and lactation period
- Not applying permanent epilation
- Not using temporary hair reduction methods in the last 4 weeks
- Not using oral contraceptive, corticosteroid, cyclosporin or spironolactone in the last 3 months
You may not qualify if:
- Female patients below the age of 18, above 45 and men in any age group
- Pregnant women and women in lactation period
- Patients who had permanent epilation
- Patients who had temporary hair reduction methods in the last 4 weeks
- Patients taking oral contraceptive, corticosteroid, cyclosporin or spironolactone in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (26)
Adana City Training and Research Hospital
Adana, 01358, Turkey (Türkiye)
School of Medicine, Aksaray University
Aksaray, 68000, Turkey (Türkiye)
School of Medicine, Ankara Yıldırım Beyazıt University
Ankara, 06010, Turkey (Türkiye)
School of Medicine, Aydın Adnan Menderes University
Aydin, 09100, Turkey (Türkiye)
Bitlis Tatvan State Hospital
Bitlis, 13200, Turkey (Türkiye)
School of Medicine, Uludag University
Bursa, 16285, Turkey (Türkiye)
University of Health Sciences, Gazi Yasargil Training and Research Hospital
Diyarbakır, 21070, Turkey (Türkiye)
School of Medicine, Trakya University
Edirne, 22030, Turkey (Türkiye)
School of Medicine, Eskisehir Osmangazi University
Eskişehir, 26040, Turkey (Türkiye)
School of Medicine, Gaziantep University
Gaziantep, 27310, Turkey (Türkiye)
School of Medicine, Süleyman Demirel University
Isparta, 32260, Turkey (Türkiye)
University of Health Sciences, Bakırköy Sadi Konuk Training and Research Hospital
Istanbul, 34147, Turkey (Türkiye)
University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital
Istanbul, 34668, Turkey (Türkiye)
Istanbul Medeniyet University, Goztepe Research and Training Hospital
Istanbul, 34730, Turkey (Türkiye)
University of Health Sciences, Umraniye Training and Research Hospital
Istanbul, 34764, Turkey (Türkiye)
Marmara University Pendik Training and Research Hospital
Istanbul, 34899, Turkey (Türkiye)
School of Medicine,Izmir Katip Celebi University
Izmir, 35620, Turkey (Türkiye)
School of Medicine,Kahramanmaras Sutcu Imam University
Kahramanmaraş, 46050, Turkey (Türkiye)
School of Medicine, Kocaeli University
Kocaeli, 41001, Turkey (Türkiye)
Meram School of Medicine, Necmettin Erbakan University
Konya, 42090, Turkey (Türkiye)
School of Medicine, Celal Bayar University
Manisa, 45140, Turkey (Türkiye)
Sanlıurfa Training and Research Hospital
Sanliurfa, 63300, Turkey (Türkiye)
School of Medicine, Namık Kemal University
Tekirdağ, 59030, Turkey (Türkiye)
School of Medicine,Tokat Gaziosmanpasa University
Tokat Province, 60030, Turkey (Türkiye)
School of Medicine,Karadeniz Technical University
Trabzon, 61080, Turkey (Türkiye)
University of Health Sciences, Van Training and Research Hospital
Van, 65100, Turkey (Türkiye)
Related Publications (4)
Li R, Qiao J, Yang D, Li S, Lu S, Wu X, Wei Z. Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system. Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):165-9. doi: 10.1016/j.ejogrb.2012.03.023. Epub 2012 Jun 28.
PMID: 22748844BACKGROUNDLumezi BG, Berisha VL, Pupovci HL, Goci A, Hajrushi AB. Grading of hirsutism based on the Ferriman-Gallwey scoring system in Kosovar women. Postepy Dermatol Alergol. 2018 Dec;35(6):631-635. doi: 10.5114/ada.2018.77615. Epub 2018 Nov 13.
PMID: 30618534BACKGROUNDFatemi Naeini F, Najafian J, Jazebi N. Hirsutism and body mass index in a representative sample of Iranian people. ARYA Atheroscler. 2012 Spring;8(1):43-54.
PMID: 23056100BACKGROUNDCarmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol. 1998 Oct;139(4):421-3. doi: 10.1530/eje.0.1390421.
PMID: 9820619BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Filiz Cebeci Kahraman, Assoc. Prof.
University of Health Sciences, Goztepe Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 26, 2020
First Posted
March 3, 2020
Study Start
February 3, 2020
Primary Completion
September 30, 2020
Study Completion
September 30, 2020
Last Updated
March 3, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share